Nakase, Hiroshi
Esaki, Motohiro
Hirai, Fumihito
Kobayashi, Taku
Matsuoka, Katsuyoshi
Matsuura, Minoru
Naganuma, Makoto
Saruta, Masayuki
Tsuchiya, Kiichiro
Uchino, Motoi
Watanabe, Kenji
Hisamatsu, Tadakazu http://orcid.org/0000-0002-1178-3536
Andoh, Akira
Bamba, Shigeki
Esaki, Motohiro
Fujiya, Mikihiro
Futami, Kitaro
Hata, Keisuke
Hirai, Fumihito
Hiraoka, Sakiko
Hisamatsu, Tadakazu http://orcid.org/0000-0002-1178-3536
Hokari, Ryota
Ishihara, Shunji
Ishihara, Soichiro
Itabashi, Michio
Kakuta, Yoichi
Kato, Jun
Kato, Shingo
Katsurada, Takehiko
Kitamura, Kazuya
Kobayashi, Kiyonori
Kobayashi, Taku
Koganei, Kazutaka
Maemoto, Atsuo
Matsui, Toshiyuki
Matsumoto, Takayuki
Matsuoka, Katsuyoshi
Matsuura, Minoru
Motoya, Satoshi
Nagahori, Masakazu
Naganuma, Makoto
Naito, Yuji
Nakamura, Shiro
Nakase, Hiroshi
Ogata, Haruhiko
Okazaki, Kazuichi
Sakuraba, Hirotake
Saruta, Masayuki
Shinzaki, Shinichiro
Sugimoto, Ken
Sugita, Akira
Suzuki, Yasuo
Takahashi, Kenichi
Takagi, Tomohisa
Takenaka, Kento
Takeuchi, Ken
Tsuchiya, Kiichiro
Tsujikawa, Tomoyuki
Uchino, Motoi
Ueno, Fumiaki
Watanabe, Kenji
Watanabe, Mamoru
Yamamoto, Takayuki
Yokoyama, Kaoru
Yoshida, Atsushi
Yoshimura, Naoki
,
Funding for this research was provided by:
AbbVie
Article History
Received: 29 September 2022
Accepted: 8 January 2023
First Online: 11 February 2023
Declarations
:
: All authors received honoraria and administration costs from AbbVie to attend the meetings. Financial arrangements of the authors with companies whose products may be related to the present report are listed below, as declared by the authors. Hiroshi Nakase has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for AbbVie GK, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Mylan EPD G.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd.; research grants from AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., PENTAX Medical, AYUMI Pharmaceutical Corporation; scholarship grants from AbbVie GK, EA Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nippon Kayaku Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd. Motohiro Esaki has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for Mitsubishi Tanabe Pharma Corporation, AbbVie GK, Janssen Pharmaceutical K.K., EA Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd.; scholarship grants from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, Takeda Pharmaceutical Co., Ltd. Fumihito Hirai has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for AbbVie GK, EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd.; research grants from Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., and AbbVie GK; scholarship grants from AbbVie GK, EA Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation. Taku Kobayashi has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for AbbVie GK, Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc.; research grants from AbbVie GK, Activaid, Alfresa Pharma Corporation, JMDC, Gilead Sciences, Nippon Kayaku Co., Ltd., Eli Lilly Japan K.K., Mochida Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Google Asia Pacific Pty. Ltd.; scholarship grants from Mitsubishi Tanabe Pharma Corporation, Zeria Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd.; and was an endowed chair for Otsuka Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., JIMRO Co., Ltd., AbbVie GK, Zeria Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., and Mochida Pharmaceutical Co., Ltd. Katsuyoshi Matsuoka has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., AbbVie GK, EA Pharma Co., Ltd., Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd.; research grants from Janssen Pharmaceutical K.K.; scholarship grants from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd. Minoru Matsuura has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for Janssen Pharmaceutical K.K. Makoto Naganuma has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for Takeda Pharmaceutical Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Pfizer Japan Inc.; research grants from Mochida Pharmaceutical Co., Ltd.; scholarship grants from AbbVie GK, Mitsubishi Tanabe Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd. Masayuki Saruta has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for AbbVie GK, Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Ltd., Takeda Pharmaceutical Co., Ltd., EA Pharma Co., Ltd.; fees for writing a pamphlet for EA Pharma Co., Ltd.; research grants from EPS Corporation; scholarship grants from Mochida Pharmaceutical Co., Ltd., Kiichiro Tsuchiya and Motoi Uchino have no conflicts of interest to declare. Kenji Watanabe has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for AbbVie GK, EA Pharma Co., Ltd., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., research grants from EA Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., EP-CRSU Co., Ltd., scholarship grants from AbbVie GK, EA Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Ltd., Nippon Kayaku Co., Ltd., and has been an endowed chair for AbbVie GK, EA Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Zeria Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Asahi Kasei Medical Co., Ltd., Mochida Pharmaceutical Co., Ltd. Tadakazu Hisamatsu has received honoraria and had expenses paid to attend or give a presentation or advice at a meeting for EA Pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Japan Inc., Nichi-Iko Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA Pharma Co. Ltd., Kyorin Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Japan Inc.; research grants from Alfresa Pharma Corporation, EA Pharma Co., Ltd.; scholarship grants from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co., Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd. AbbVie, the sponsor, had no involvement in the development of the statements or the drafting of the current manuscript.